XM无法为美国居民提供服务。
N
N

Novartis

交易方向

交易者偏好

技术摘要

每小时

市场新闻

US judicial panel to examine litigation finance disclosure

UPDATE 1-US judicial panel to examine litigation finance disclosure Adds comment from litigation funding group in paragraph 16 By Nate Raymond Oct 10 (Reuters) - A federal judicial rules-making panel on Thursday agreed to study whether a nationwide rule requiring disclosure of third-party litigation funding in lawsuits is necessary at the urging of major companies, business groups and Republican lawmakers .
A
B
C
G
N
P

US judicial panel to examine litigation finance disclosure

US judicial panel to examine litigation finance disclosure By Nate Raymond Oct 10 (Reuters) - A federal judicial rules-making panel on Thursday agreed to study whether a nationwide rule requiring disclosure of third-party litigation funding in lawsuits is necessary at the urging of major companies, business groups and Republican lawmakers . After a decade of weighing whether it should do anything to regulate the emerging field of litigation finance, the U.S.
A
B
C
G
N
P

Swiss competition authority closes Novartis probe without consequences

UPDATE 1-Swiss competition authority closes Novartis probe without consequences Adds EU Commission in final two paragrahs BERLIN, Oct 10 (Reuters) - Switzerland's COMCO competition commission terminated an investigation against Novartis NOVN.S into possibly using blocking patents, without consequences, it said on Thursday. COMCO opened the probe in September 2022 to determine whether the pharmaceutical giant intended to unlawfully protect one if its medicines by filing various patent infringemen
N

Swiss competition authority closes Novartis probe without consequences

Swiss competition authority closes Novartis probe without consequences BERLIN, Oct 10 (Reuters) - Switzerland's COMCO competition commission terminated an investigation against Novartis NOVN.S into possibly using blocking patents, without consequences, it said on Thursday. COMCO opened the probe in September 2022 to determine whether the pharmaceutical giant intended to unlawfully protect one if its medicines by filing various patent infringement lawsuits, the commission said in a statement.
N

US lawmaker calls for litigation funding disclosures

US lawmaker calls for litigation funding disclosures By Sara Merken Oct 7 (Reuters) - A federal lawmaker has introduced legislation that would require the disclosure of third-party funding in civil lawsuits. U.S. Republican Representative Darrell Issa of California on Friday introduced a bill that calls for parties in civil litigation to tell the court and other named parties the identity of third-party that has the right to receive payment that is contingent on the outcome of a case or group or
A
B
C
G
N
P

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明